Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Asthma is increasing in prevalence worldwide and results in significant use of healthcare resources. Although most patients with asthma can be adequately treated with inhaled corticosteroids, an important number of patients require additional therapy and an increasing number of options are available. A further minority of patients develop severe persistent asthma which remains difficult to manage despite current pharmacological therapies. This review discusses the various treatment options currently available for each stage of asthma severity, highlights some of the limitations of current management, and outlines directions which may improve the management of asthma in the future.

Type

Journal article

Journal

Postgrad Med J

Publication Date

05/2003

Volume

79

Pages

259 - 267

Keywords

Adrenal Cortex Hormones, Adrenergic beta-2 Receptor Antagonists, Allergens, Anti-Asthmatic Agents, Antibodies, Monoclonal, Asthma, Forecasting, Humans, Immunotherapy, Interleukins, Leukotriene Antagonists, Respiratory Therapy, Self Care, Smoking Cessation, Theophylline